Treatment of recurrent HCV infection following liver transplantation: Results of a multicenter, randomized, versus placebo, trial of ribavirin alone as maintenance therapy after one year of PegIFNα-2a plus ribavirin
Yvon Calmus, Christophe Duvoux, Georges Pageaux, Philippe Wolf, Lionel Rostaing, Claire Vanlemmens, Danielle Botta-Fridlund, Sébastien Dharancy, Jean Gugenheim, François Durand, Martine Néau-Cransac,Том:
57
Рік:
2012
Мова:
english
DOI:
10.1016/j.jhep.2012.04.022
Файл:
PDF, 902 KB
english, 2012
File converter
Більше результатів пошуку
More benefits 
